ArticleTurkish journal of medical sciences2024
Effect of ΔNp63β on cell cycle and apoptosis in T98G cells.
Article in Turkish journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: The p53 protein, a crucial tumor suppressor, governs cell cycle regulation and apoptosis. Similarly, p63, a member of the p53 family, exhibits traits of both tumor suppression and oncogenic behavior through its isoforms. However, the functional impact of ΔNp63β, an isoform of the p63 protein, on human glioma cancer cells like T98G cells remains poorly understood, representing the novelty of this study in the current literature. Materials and methods: Employing the pRetroX-Tet-On vector system, the apoptotic effects of ΔNp63β on T98G cell lines was investigated and its influence on the cell cycle was assessed. Initially, an rtTA-expressing vector, a component of the pRetroX-Tet-On system, was established in the T98G cell lines. Subsequently, the ΔNp63β cDNA was cloned into the Retropur Tight retroviral vector and transfected into T98G cells containing the pRetroX-Tet-On system for functional analysis. The gene expression and cell cycle regulation were evaluated through reverse-transcription polymerase chain reaction and flow cytometry, determining protein translation via western blotting. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and β-galactosidase cell staining were employed to assess the cytotoxicity and senescence of ΔNp63β, respectively. Results: The overexpression of ΔNp63β in the T98G cells correlated with increased cell viability and altered cell cycle regulation, notably upregulating the p21 expression independent of p53. Caspase-3/7 activity analyses showed no changes in the apoptotic genes but revealed an increase in antiapoptotic gene expression. Surprisingly, cell death in the ΔNp63β-overexpressing T98G cells did not occur through apoptosis as anticipated. Instead, it resulted from the cytotoxic effects of the ΔNp63β protein. Conclusion: Δp63β increased the p21 levels, induced cell death, and caused cell cycle arrest at the G1 phase, while exhibiting antiapoptotic properties and promoting senescence. Unexpectedly, overexpression of Δp63β in T98G cells led to significant cell death, potentially through necrosis rather than apoptosis, suggesting a complex role for Δp63β in cell cycle regulation and tumor suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.